The Effect of the Modified Perineal Protection Device During Delivery

NCT ID: NCT02013752

Last Updated: 2015-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

PHASE2/PHASE3

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-03-31

Study Completion Date

2015-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine whether a modified perineum protection device can reduce tearing during delivery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

RCT investigation using a modified device during delivery of the baby's head (an earlier model has proved successful) and assess whether the use can decrease delivery tears as measured in length.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perineal Tears.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Perineal device during delivery

Delivery should be managed by using the perineal protection device when the head was crowning and 5-6 cm of it was visible. One part the "tongue" was inserted between the head and the posterior vaginal wall and the "two wings" were held against the perineum and kept in place by the delivery attendant's hand.

Group Type ACTIVE_COMPARATOR

Perineal protection device.

Intervention Type DEVICE

A device used to reduce perineal tears during delivery of the baby.

Standard care

Standard care at delivery: Manual support of the perineum

Group Type OTHER

Perineal protection device.

Intervention Type DEVICE

A device used to reduce perineal tears during delivery of the baby.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Perineal protection device.

A device used to reduce perineal tears during delivery of the baby.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

The perineal protection device have no brand name.

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Vaginal delivery at term (week 36 - 41)

Exclusion Criteria

* Age below 18
* Breech delivery
* Not understanding written and oral information
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Knut Haadem

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Knut Haadem

M.D., PhD

Responsibility Role SPONSOR_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Knut Haadem, M.D., PhD

Role: PRINCIPAL_INVESTIGATOR

Campus Helsingborg, Clinical Science Faculty of Medicine, Lund University, Helsingborg, Sweden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Dept Obstetrics and Gynecology, Helsingborg Hospital

Helsingborg, Skåne County, Sweden

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Knut Haadem, M.D. PhD

Role: CONTACT

0046739549946

Tony Lavesson, M.D

Role: CONTACT

0046424062205

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Knut Haadem, MD, PhD

Role: primary

0046739549946

Tony Lavesson, MD

Role: backup

0046424062205

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ONLY-HBG

Identifier Type: REGISTRY

Identifier Source: secondary_id

KH-HBG-13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.